The role of long non-coding RNAs in developing paclitaxel-resistant triple negative breast cancer: a systematic review
OncologiaSobre o estudo
- Desenho
- Revisão sistemática
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Cancer treatment and research communications
- Publicado em
- 30 abr 2025
- Citações
- 4
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
The role of long non-coding RNAs in developing paclitaxel-resistant triple negative breast cancer: a systematic review
Davood Dalil, Saeid Iranzadeh, Alireza Barouh, Zahra Ghorbanniadelavar, Mohammad Mahdi Mehrabi
Descritores MeSH
- Triple Negative Breast Neoplasms
- Paclitaxel
- Drug Resistance, Neoplasm
- RNA, Long Noncoding
- Antineoplastic Agents, Phytogenic
- Female
- Humans
- Gene Expression Regulation, Neoplastic
- Epithelial-Mesenchymal Transition
Veja também
Estudos relacionados
- LncRNAs orchestration of gastric cancer - particular emphasis on the etiology, diagnosis, and treatment resistance
- Reawakening the master switches in triple-negative breast cancer: A strategic blueprint for confronting metastasis and chemoresistance via microRNA-200/205: A systematic review
- Exosomal Non-Coding RNAs in Gastrointestinal Cancer Drug Resistance: A Systematic Review of Emerging Mechanisms and Clinical Implications
- Non-Coding RNA-Based Therapeutic Strategies in Triple-Negative Breast Cancer: A Systematic Review